戻る Agenda
Session 5: Keynote Address
Session Chair(s)
James Wild, PhD
Pharmacologist, CDER
FDA, United States
Session 5: Keynote Address
Speaker(s)
Session Co-Chair
James D. Thompson, PhD
Moderna Therapeutics , United States
CMC Therapeutic Area Lead
Keynote
Philip (P.J.) Brooks, PhD
National Center for Advancing Translational Sciences (NCATS), NIH, United States
Deputy Director, Division of Rare Diseases Research Innovation
Speaker
Arthur M. Krieg, MD
Checkmate Pharmaceuticals, United States
CEO and CSO